Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2007 Filed Feb 21, 2007 23:20 UTC |
Bohuon OlivierSenior Vice President
|
GrantCommon shares without par value | 4,167 | $52.49 | $218,725.83 |
DisclosureSEC source: 0001104659-07-012793 · a4.xml · nonDerivative · entry 1 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,997 F1 · kind: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:49 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 112,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012303 · a4.xml · derivative · entry 8 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: common shares · 112,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 2/16/08, 37,333 on 2/16/09 and 37,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:49 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012303 · a4.xml · nonDerivative · entry 3 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,928 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:49 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantCommon shares without par value | 27,600 | $52.54 | $1,450,104.00 |
DisclosureSEC source: 0001104659-07-012303 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,928 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 112,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · derivative · entry 12 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: common shares · 112,000 shares Expires 2017-02-15 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 2/16/08, 37,333 on 2/16/09 and 37,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · nonDerivative · entry 4 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,566 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 27,600 | $52.54 | $1,450,104.00 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,566 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:53 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 302,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · derivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,000 Underlying: common shares · 302,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 100,667 on 2/16/08, 100,667 on 2/16/09 and 100,666 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:53 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantCommon shares without par value | 125,000 | $52.54 | $6,567,500.00 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,156 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:51 UTC |
CAPEK JOHN MSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012307 · a4.xml · derivative · entry 3 CAPEK JOHN M · CIK 0001328034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2017-02-15 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/16/2008, 27,667 on 2/16/09, and 27,666 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:51 UTC |
CAPEK JOHN MSenior Vice President
|
GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012307 · a4.xml · nonDerivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,400 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:51 UTC |
CAPEK JOHN MSenior Vice President
|
GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012307 · a4.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,400 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2017-02-15 F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009 and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Landgraf John CSenior Vice President
|
GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,240 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Landgraf John CSenior Vice President
|
GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,240 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:54 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012311 · a4.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,674 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:54 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 55,200 | $52.54 | $2,900,208.00 |
DisclosureSEC source: 0001104659-07-012311 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,674 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012363 · a4.xml · derivative · entry 10 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2017-02-15 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009, and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Chen Thomas FSenior Vice President
|
GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012363 · a4.xml · nonDerivative · entry 3 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,820 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Chen Thomas FSenior Vice President
|
GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012363 · a4.xml · nonDerivative · entry 2 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,820 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:56 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 35,700 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012365 · a4.xml · derivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,700 Underlying: Common Shares · 35,700 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 11,900 on 02/16/2008, 11,900 on 02/16/2009, and 11,900 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:56 UTC |
LINDER GREG WVice President
|
GrantCommon shares without par value | 15,000 | $52.54 | $788,100.00 |
DisclosureSEC source: 0001104659-07-012365 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,057 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:56 UTC |
LINDER GREG WVice President
|
GrantCommon shares without par value | 10,000 | $52.54 | $525,400.00 |
DisclosureSEC source: 0001104659-07-012365 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,057 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012364 · a4.xml · derivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009, and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Fussell Stephen RSenior Vice President
|
GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012364 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,226 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:55 UTC |
Fussell Stephen RSenior Vice President
|
GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012364 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,226 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:24 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 112,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · derivative · entry 12 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: common shares · 112,000 shares Expires 2017-02-15 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 2/16/2008, 37,333 on 2/16/09, and 37,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:24 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,632 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:24 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantCommon shares without par value | 27,600 | $52.54 | $1,450,104.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,632 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012366 · a4.xml · derivative · entry 6 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2017-02-15 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009 and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012366 · a4.xml · nonDerivative · entry 2 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,489 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012366 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,489 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 112,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · derivative · entry 11 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: common shares · 112,000 shares Expires 2017-02-15 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 2/16/2008, 37,333 on 2/16/09, and 37,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,786 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantCommon shares without par value | 27,600 | $52.54 | $1,450,104.00 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,786 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:40 UTC |
Schumacher Laura JSenior Vice President
|
GrantOption (right to buy) · Derivative | 112,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012383 · a4.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: Common shares · 112,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 02/16/2008, 37,333 on 02/16/2009 and 37,333 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:40 UTC |
Schumacher Laura JSenior Vice President
|
GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012383 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,304 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:40 UTC |
Schumacher Laura JSenior Vice President
|
GrantCommon shares without par value | 27,600 | $52.54 | $1,450,104.00 |
DisclosureSEC source: 0001104659-07-012383 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,304 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:25 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · derivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2017-02-15 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009, and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:25 UTC |
Hance Robert BSenior Vice President
|
GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,015 F3 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:25 UTC |
Hance Robert BSenior Vice President
|
GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,015 F2 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:50 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012388 · a4.xml · derivative · entry 9 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009 and 27,666 on 02/16/2010. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:50 UTC |
Tyree James LSenior Vice President
|
GrantCommon shares without par value | 17,000 | $52.54 | $893,180.00 |
DisclosureSEC source: 0001104659-07-012388 · a4.xml · nonDerivative · entry 4 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,005 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:50 UTC |
Tyree James LSenior Vice President
|
GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012388 · a4.xml · nonDerivative · entry 3 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,005 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 00:07 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 550,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · derivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: common shares · 550,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 183,334 on 2/16/08, 183,333 on 2/16/09 and 183,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 00:07 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 140,000 | $52.54 | $7,355,600.00 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,073 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 23:20 UTC |
Bohuon OlivierSenior Vice President
|
GrantRestricted Stock Unit · Derivative | 17,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-012793 · a4.xml · derivative · entry 3 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: common shares · 17,000 shares Expires not disclosed F3 · security: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program. The units generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Each unit represents the contingent right to receive one Abbott common share. F3 · derivative.exercise_date: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program. The units generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Each unit represents the contingent right to receive one Abbott common share. F3 · derivative.expiration_date: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program. The units generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Each unit represents the contingent right to receive one Abbott common share. Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 23:20 UTC |
Bohuon OlivierSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012793 · a4.xml · derivative · entry 2 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2017-02-15 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/16/2008, 27,667 on 2/16/09, and 27,666 on 2/16/10. Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 21:49 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Tax withholdingCommon shares without par value | 9,863 | $52.70 | $519,780.10 |
DisclosureSEC source: 0001104659-07-012303 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,328 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 9,863 | $52.70 | $519,780.10 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,966 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.